Department of Restorative, Preventive and Pediatric Dentistry, School of Dental Medicine, University of Bern, Switzerland.
Department of Restorative, Preventive and Pediatric Dentistry, School of Dental Medicine, University of Bern, Switzerland.
J Dent. 2021 Jun;109:103652. doi: 10.1016/j.jdent.2021.103652. Epub 2021 Mar 30.
INTRODUCTION/OBJECTIVES: The present review systematically analyzed clinical studies investigating the efficacy of self-assembling peptides (SAP) to reduce initiation of or to remineralize initial caries lesions.
Prospective controlled (non-)randomized clinical trials investigating the efficacy of a self-assembling peptide compared to any other (placebo) treatment or untreated/standard control. Outcomes were visual analog scale (VAS), laser fluorescence, ICDAS score or morphometric measurements.
Three electronic databases (Central, PubMed, Ovid EMBASE) were screened. No language or time restrictions were applied.. Risk of Bias and level of evidence was graded using Risk of Bias 2.0 tool and Grade Profiler 3.6.
STUDY SELECTION/RESULTS: Seven studies with 508 teeth being affected in 294 patients were included. All studies were randomized controlled trials (RCT), five with a split-mouth and two with a parallel-arm design. Meta-analysis could be performed for SAP (plus fluoride varnish (FV)) vs. no treatment (plus FV) (control treatment). Depending on the outcome after up to 12 months SAP showed a significantly higher optical improvement than the control treatment (laser fluorescence: Standardized Mean Difference (SMD)[95 %CI] = -0.87[-1.39,-0.34; VAS: Mean Difference (MD)[95 %CI] = -35.38[-43.13,-27.64]) or no significant difference could be observed (ICDAS/activity score; Relative Risk (RR)[95 %CI] = 0.6[0.21,1.74]; morphometric measurements: SMD[95 %CI] = -1.95[-4.54,0.65]). Level of evidence was very low for all 4 outcomes. Furthermore, six studies showed a high risk of bias and six studies were (partially) funded by the manufactures of the tested products.
Based on a low number of clinical trials with relatively short follow up-periods and high risks of bias, self-assembling peptides may be a viable option to remineralize enamel caries.
Self-assembling peptides may be a viable option to remineralize enamel caries. However, results should be interpretated with caution due the low number of clinical trials, the short follow-up periods and the limiting grade of evidence.
简介/目的:本综述系统分析了研究自组装肽(SAP)减少龋齿初始病变发生或再矿化的临床研究。
前瞻性对照(非)随机临床试验,比较自组装肽与任何其他(安慰剂)治疗或未治疗/标准对照的疗效。结果采用视觉模拟评分(VAS)、激光荧光、ICDAS 评分或形态测量。
筛选了三个电子数据库(CENTRAL、PubMed、ovid EMBASE)。未限制语言或时间。使用风险偏倚 2.0 工具和等级分析器 3.6 对风险偏倚和证据水平进行分级。
研究选择/结果:纳入了 7 项研究,共涉及 294 名患者的 508 颗牙齿。所有研究均为随机对照试验(RCT),其中 5 项为分口设计,2 项为平行臂设计。对 SAP(加氟保护漆(FV))与无治疗(加 FV)(对照治疗)进行了 meta 分析。在长达 12 个月的随访后,SAP 显示出比对照治疗更高的光学改善,这具有统计学意义(激光荧光:标准化均数差(SMD)[95%CI] =-0.87[-1.39,-0.34;VAS:平均差值(MD)[95%CI] =-35.38[-43.13,-27.64]),或无显著差异(ICDAS/活动评分;相对风险(RR)[95%CI] =0.6[0.21,1.74];形态测量:SMD[95%CI] =-1.95[-4.54,0.65])。所有 4 个结局的证据水平均非常低。此外,6 项研究显示出较高的偏倚风险,6 项研究部分由所测试产品的制造商资助。
基于数量相对较少的短期随访临床试验和高偏倚风险,自组装肽可能是再矿化釉质龋的一种可行选择。
自组装肽可能是再矿化釉质龋的一种可行选择。然而,由于临床试验数量较少、随访时间较短以及证据等级有限,结果应谨慎解释。